Fundz

Singapore's ChemT Biotechnology raises $4 million in Seed funding led by Wavemaker Ventures to expand its AI-driven platform for biomanufacturing.

PRIVATEJun 22, 2026

Amount Raised

$4 Million

Round Type

Seed

SingaporeManufacturingBiotechnologyArtificial IntelligenceMachine Learning

Investors

SeedsWavemaker 360 HealthDraper University VenturesTemasek Life Sciences AcceleratorWavemaker Ventures

Description

ChemT Biotechnology has secured $4 million in its Seed funding round to enhance its AI-driven platform aimed at improving biomanufacturing processes. The round was backed by Wavemaker Ventures and SEEDS, among other investors. This funding will support the expansion of their AI and experimental infrastructure. The total funding raised by ChemT in 18 months has now reached $5 million.

Who to call at ChemT Biotechnology, and when

A new round usually means ChemT Biotechnology is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ChemT Biotechnology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ChemT Biotechnology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ChemT Biotechnology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ChemT Biotechnology

Location

Singapore

About

ChemT Biotechnology is a Singapore-based startup focused on using artificial intelligence (AI) to enhance biomanufacturing processes. The company specifically aims to tackle challenges in the pharmaceutical industry related to long development timelines and high production costs. Its core technology, CelMo, is an AI-powered platform that simulates cellular responses to improve productivity and scalability in biologics manufacturing. ChemT aims to expand its AI-driven solutions for various types of cells used in production.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ChemT Biotechnology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJie S., Co-Founder & CEO hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for ChemT Biotechnology's next move

See what Strategic adds

ChemT Biotechnology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.